[1]
M. Z. Kidwai and M. Bindra, “Assessment of nitric oxide and peroxiredoxin along with frap in newly diagnosed patients of type 2 diabetes mellitus”, Heal. Sci. Int. J., vol. 2, no. 1, pp. 1–12, Feb. 2024, doi: 10.71357/hsij.v2i1.10.